| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Jun 6, 2025 | Stoke Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -3,000,000 | -43.44% | ✗ | $30.6M |
| Dec 23, 2024 | Dec 27, 2024 | Stoke Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -2,000,000 | -22.46% | ✗ | $23M |
| Sep 19, 2024 | Sep 23, 2024 | Stoke Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -1,937,500 | -17.87% | ✗ | $27.2M |
| Apr 17, 2024 | Apr 18, 2024 | Stoke Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -3,600,000 | -24.92% | ✗ | $41.8M |
| Dec 1, 2022 | Dec 5, 2022 | Akero Therapeutics, Inc. | Other | Sell | 15.0 | -1,636,000 | -33.33% | ✗ | $71.2M |